Skip to main content

Alveolar Soft Part Sarcoma News

Related terms: ASPS

Atezolizumab Can Induce Response in Alveolar Soft Part Sarcoma

THURSDAY, Sept. 7, 2023 – The immunotherapy agent atezolizumab induces sustained responses in about one-third of patients with advanced alveolar soft part sarcoma (ASPS), according to a study...

Ask a question

To post your own question to this support group, sign in or create an account.